Cargando…

Titer on Chip: New Analytical Tool for Influenza Vaccine Potency Determination

Titer on Chip (Flu-ToC) is a new technique for quantification of influenza hemagglutinin (HA) concentration. In order to evaluate the potential of this new technique, a comparison of Flu-ToC to more conventional methods was conducted using recombinant HA produced in a baculovirus expression system a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuck, Laura R., Sorensen, Michelle, Matthews, Erin, Srivastava, Indresh, Cox, Manon M. J., Rowlen, Kathy L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203742/ https://www.ncbi.nlm.nih.gov/pubmed/25330238 http://dx.doi.org/10.1371/journal.pone.0109616

Ejemplares similares

A neuraminidase potency assay for quantitative assessment of neuraminidase in influenza vaccines
por: Byrne-Nash, Rose T., et al.
Publicado: (2019)

VaxArray potency assay for rapid assessment of “pandemic” influenza vaccines
por: Byrne-Nash, Rose T., et al.
Publicado: (2018)

Influenza vaccine titer determination using biolayer interferometry (BLI)
por: Wheatley, David W, et al.
Publicado: (2015)

Analytical evaluation of the microarray-based FluChip-8G Influenza A+B Assay
por: Taylor, Amber W., et al.
Publicado: (2019)

Modifications of cysteine residues in the transmembrane and cytoplasmic domains of a recombinant hemagglutinin protein prevent cross-linked multimer formation and potency loss
por: Holtz, Kathleen M, et al.
Publicado: (2014)

Selection of appropriate analytical tools to determine the potency and bioactivity of antibiotics and antibiotic resistance()
por: Dafale, Nishant A., et al.
Publicado: (2016)

Strategies to generate high-titer, high-potency recombinant AAV3 serotype vectors
por: Ling, Chen, et al.
Publicado: (2016)

FluChip‐8G Insight: HA and NA subtyping of potentially pandemic influenza A viruses in a single assay
por: Toth, Evan, et al.
Publicado: (2019)

COMPARISON OF THE POTENCY OF POLYVALENT ANTIMENINGOCOCCUS SERUM PRODUCED WITH FOUR AND SIX REPRESENTATIVE STRAINS AND THAT PRODUCED WITH SIXTY STRAINS, AS DETERMINED BY THE AGGLUTINATION TITER
por: Wadsworth, Augustus B.
Publicado: (1921)

Automated interpretation of influenza hemagglutination inhibition (HAI) assays: Is plate tilting necessary?
por: Wilson, Garrett, et al.
Publicado: (2017)

Assaying the Potency of Influenza Vaccines
por: Minor, Philip D.
Publicado: (2015)

ATIVS: analytical tool for influenza virus surveillance
por: Liao, Yu-Chieh, et al.
Publicado: (2009)

Multiplexed, microscale, microarray-based serological assay for antibodies against all human-relevant coronaviruses
por: Dawson, Erica D., et al.
Publicado: (2021)

Evaluation of SARS‐CoV‐2 antibody titers and potency for convalescent plasma donation: a brief commentary
por: Wouters, Elise, et al.
Publicado: (2020)

Complete study demonstrating the absence of rhabdovirus in a distinct Sf9 cell line
por: Hashimoto, Yoshifumi, et al.
Publicado: (2017)

Determination of influenza B identity and potency in quadrivalent inactivated influenza vaccines using lineage-specific monoclonal antibodies
por: Verma, Swati, et al.
Publicado: (2017)

Comparability of Titers of Antibodies against Seasonal Influenza Virus Strains as Determined by Hemagglutination Inhibition and Microneutralization Assays
por: Heeringa, Marten, et al.
Publicado: (2020)

Determination of the Tool–Chip Contact Length for the Cutting Processes
por: Storchak, Michael, et al.
Publicado: (2022)

THE RELATION OF INFECTIOUS AND HEMAGGLUTINATION TITERS TO THE ADAPTATION OF INFLUENZA VIRUS TO MICE
por: Wang, Cheng-I
Publicado: (1948)

Repeated Influenza Vaccination Boosts and Maintains H1N1pdm09 Neuraminidase Antibody Titers
por: Hansen, Lena, et al.
Publicado: (2021)

An ELISA-based assay for determining haemagglutinin potency in egg, cell, or recombinant protein derived influenza vaccines
por: Bodle, Jesse, et al.
Publicado: (2023)

Structure of general-population antibody titer distributions to influenza A virus
por: Nhat, Nguyen Thi Duy, et al.
Publicado: (2017)

The in vivo efficacy of neuraminidase inhibitors cannot be determined from the decay rates of influenza viral titers observed in treated patients
por: Palmer, John, et al.
Publicado: (2017)

Detection of Analytes on Arrays/Microarrays/DNA Chips
por: Sadana, Ajit, et al.
Publicado: (2011)

Potency Testing of Venoms and Antivenoms in Embryonated Eggs: An Ethical Alternative to Animal Testing
por: Verity, Erin E., et al.
Publicado: (2021)

410. Influence of Pre-season Antibody Titers to Influenza on Influenza Risk in a Cohort of Healthcare Personnel
por: Rattigan, Susan M, et al.
Publicado: (2019)

Collaborative studies on the development of national reference standards for potency determination of H7N9 influenza vaccine
por: Li, Changgui, et al.
Publicado: (2015)

Determination of H5N1 vaccine potency using reference antisera from heterologous strains of influenza
por: Vodeiko, Galina M., et al.
Publicado: (2011)

Rapid determination of influenza vaccine potency by an SPR-based method using subtype or lineage-specific monoclonal antibodies
por: Narayan, Kartik, et al.
Publicado: (2023)

A purified MAA-based ELISA is a useful tool for determining anti-MAA antibody titer with high sensitivity
por: Shimomoto, Takasumi, et al.
Publicado: (2017)

Growth Curves of Influenza Virus based on Hemagglutination Titers in Individual Embryonated Eggs
por: Freymann, M. W., et al.
Publicado: (1951)

Measuring Influenza Neuraminidase Inhibition Antibody Titers by Enzyme-linked Lectin Assay
por: Gao, Jin, et al.
Publicado: (2016)

HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy
por: Gilbert, Peter B, et al.
Publicado: (2019)

Potency of teleophthalmology as a detection tool for diabetic retinopathy
por: Li, Liu, et al.
Publicado: (2023)

Rapid determination of SARS-CoV-2 antibody neutralization titer using Bio-Rad Bio-Plex correlates strongly with pseudovirus-determined neutralization titer
por: Heaps, Amy L., et al.
Publicado: (2023)

Influence of sample collection tube method, anticoagulant-containing plasma versus serum, on influenza virus hemagglutination inhibition titer and microneutralization titer serological assays
por: Morrison, Brian J., et al.
Publicado: (2018)

Exercise With a Novel Digital Device Increased Serum Anti-influenza Antibody Titers After Influenza Vaccination
por: Choi, Jun-Pyo, et al.
Publicado: (2023)

A novel approach for preparation of the antisera reagent for potency determination of inactivated H7N9 influenza vaccines
por: Schmeisser, Falko, et al.
Publicado: (2016)

Potency determination of inactivated H7 influenza vaccines using monoclonal antibody‐based ELISA and biolayer interferometry assays
por: Vasudevan, Anupama, et al.
Publicado: (2017)

THE ANTIGENIC POTENCY OF EPIDEMIC INFLUENZA VIRUS FOLLOWING INACTIVATION BY ULTRAVIOLET RADIATION
por: Salk, Jonas E., et al.
Publicado: (1940)

Cannot write session to /tmp/vufind_sessions/sess_dm2uargbebq4rje9qcp6dnlhfm